Linda Bao

Most-cited papers

1. Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer.

   D. Sutherlin, Linda Bao, M. Berry, G. Castanedo +27 more

   2011Journal of Medicinal Chemistry210 citations Open access

   Semantic Scholar

   Save

2. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349.

   Z. Pei, E. Blackwood, Li-Chuan Liu, S. Malek +26 more

   2013ACS Medicinal Chemistry Letters45 citations Open access

   Semantic Scholar

   Save

3. In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound

   Po‐Chang Chiang, Yong Cui, Ying-Qing Ran, J. Lubach +9 more

   2013AAPS Journal30 citations Open access

   Semantic Scholar

   Save

4. Solubilization of a Poorly Soluble B-Raf (Rapidly Accelerated Fibrosarcoma) Inhibitor: From Theory to Application.

   Linda Bao, Le An, Ying-Qing Ran

   2018Journal of Pharmacy and Science2 citations Open access

   Semantic Scholar

   Save

5. Abstract 2787: Discovery of GDC-0980, a selective PI3K/mTOR inhibitor in clinical trials

   D. Sutherlin, M. Belvin, Linda Bao, L. Berry +21 more

   20110 citations

   Semantic Scholar

   Save